tiprankstipranks
Advertisement
Advertisement

AU:OSL Stock Latest News

OncoSil Medical Posts Strong FY26 Growth as Pancreatic Cancer Device Gains Regulatory and Clinical Traction
Company AnnouncementsOncoSil Medical Posts Strong FY26 Growth as Pancreatic Cancer Device Gains Regulatory and Clinical Traction
14d ago
OSL
OncoSil Study Backs Higher-Concentration Formulations to Boost Efficiency
PremiumCompany Announcements
OncoSil Study Backs Higher-Concentration Formulations to Boost Efficiency
20d ago
OSL
OncoSil Medical Lists Additional Ordinary Shares on ASX
PremiumCompany Announcements
OncoSil Medical Lists Additional Ordinary Shares on ASX
21d ago
OSL
OncoSil Highlights Financial Position and Niche Cancer Device Focus
PremiumCompany Announcements
OncoSil Highlights Financial Position and Niche Cancer Device Focus
29d ago
OSL
OncoSil to Showcase Real-World Pancreatic Cancer Data at Major Nuclear Medicine Congress
PremiumCompany Announcements
OncoSil to Showcase Real-World Pancreatic Cancer Data at Major Nuclear Medicine Congress
1M ago
OSL
OncoSil validates scalable Australian manufacturing for pancreatic cancer device
PremiumCompany AnnouncementsOncoSil validates scalable Australian manufacturing for pancreatic cancer device
1M ago
OSL
OncoSil trial data at ESMO GI 2026 bolster case for FOLFIRINOX label expansion
Premium
Company Announcements
OncoSil trial data at ESMO GI 2026 bolster case for FOLFIRINOX label expansion
1M ago
OSL
OncoSil Seeks First U.S. Approval With FDA Filing for Cancer Device
Premium
Company Announcements
OncoSil Seeks First U.S. Approval With FDA Filing for Cancer Device
1M ago
OSL
OncoSil Joins EU PALACROS Consortium With Cost-Efficient Pancreatic Cancer Trial
PremiumCompany Announcements
OncoSil Joins EU PALACROS Consortium With Cost-Efficient Pancreatic Cancer Trial
1M ago
OSL
OncoSil trial data wins ESMO GI spotlight with promising pancreatic cancer results
PremiumCompany Announcements
OncoSil trial data wins ESMO GI spotlight with promising pancreatic cancer results
1M ago
OSL
OncoSil to Release 41,067 Escrowed Shares Issued as Director Fees
PremiumCompany Announcements
OncoSil to Release 41,067 Escrowed Shares Issued as Director Fees
2M ago
OSL
OncoSil flags FDA progress and early TRIPP-FFX data in investor update
PremiumCompany Announcements
OncoSil flags FDA progress and early TRIPP-FFX data in investor update
2M ago
OSL
OncoSil Nears Final FDA HDE Decision for Rare Bile Duct Cancer Device
PremiumCompany AnnouncementsOncoSil Nears Final FDA HDE Decision for Rare Bile Duct Cancer Device
2M ago
OSL
OncoSil Seeks Trading Halt Ahead of Key Trial Results and FDA Update
Premium
Company Announcements
OncoSil Seeks Trading Halt Ahead of Key Trial Results and FDA Update
2M ago
OSL
OncoSil on track for TRIPP-FFX data as it targets broader EU approval for pancreatic cancer device
Premium
Company Announcements
OncoSil on track for TRIPP-FFX data as it targets broader EU approval for pancreatic cancer device
2M ago
OSL
OncoSil Seeks ASX Quotation for New Employee Incentive Shares
PremiumCompany Announcements
OncoSil Seeks ASX Quotation for New Employee Incentive Shares
3M ago
OSL
OncoSil Issues New Unquoted Options Under Employee Incentive Scheme
PremiumCompany Announcements
OncoSil Issues New Unquoted Options Under Employee Incentive Scheme
3M ago
OSL
OncoSil strengthens governance with new joint company secretary
PremiumCompany Announcements
OncoSil strengthens governance with new joint company secretary
3M ago
OSL
OncoSil gains ASCO spotlight as Spanish data bolster pancreatic cancer device
PremiumCompany Announcements
OncoSil gains ASCO spotlight as Spanish data bolster pancreatic cancer device
3M ago
OSL
OncoSil Updates Market on Change in Substantial Shareholder Interests
PremiumCompany AnnouncementsOncoSil Updates Market on Change in Substantial Shareholder Interests
5M ago
OSL
OncoSil Director Increases Indirect Stake via Capital Raising
Premium
Company Announcements
OncoSil Director Increases Indirect Stake via Capital Raising
5M ago
OSL
OncoSil Flags Isolated Administrative Lapse in Director Interest Disclosure
Premium
Company Announcements
OncoSil Flags Isolated Administrative Lapse in Director Interest Disclosure
5M ago
OSL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >